carmofur has been researched along with Uterine Cervical Neoplasms in 2 studies
Uterine Cervical Neoplasms: Tumors or cancer of the UTERINE CERVIX.
| Excerpt | Relevance | Reference |
|---|---|---|
| " HCFU might be effective against gynecologic cancers when used in maintenance therapy at a lower dosage (300--400 mg) than previously estimated." | 1.27 | Concentrations of a new antitumor agent, 1-hexylcarbamoyl-5-fluorouracil in serum and gynecologic tumor tissue. ( Matsui, Y; Okudaira, Y; Sawada, M, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sawada, M | 1 |
| Matsui, Y | 1 |
| Okudaira, Y | 1 |
| Ikeda, M | 1 |
| Teshima, K | 1 |
| Noda, K | 1 |
| Yamagata, S | 1 |
| Sugawa, T | 1 |
| Okamura, S | 1 |
| Kubo, H | 1 |
| Sugimoto, O | 1 |
| Nakajima, H | 1 |
| Yamabe, T | 1 |
1 trial available for carmofur and Uterine Cervical Neoplasms
| Article | Year |
|---|---|
[Long-term administration of carmofur as a post-operative adjuvant chemotherapy for cervical adenocarcinoma. Cervical Adenocarcinoma Cooperative Research Association].
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; | 1994 |
1 other study available for carmofur and Uterine Cervical Neoplasms
| Article | Year |
|---|---|
Concentrations of a new antitumor agent, 1-hexylcarbamoyl-5-fluorouracil in serum and gynecologic tumor tissue.
Topics: Antineoplastic Agents; Female; Fluorouracil; Humans; Ovarian Neoplasms; Uterine Cervical Neoplasms | 1983 |